NASDAQ:NBIX
Neurocrine Biosciences Stock News
$135.41
-1.25 (-0.91%)
At Close: May 31, 2024
Voyager Therapeutics Announces Second Quarter 2020 Financial Results and Corporate Updates | MarketScreener
11:01am, Monday, 10'th Aug 2020Xenon Pharmaceuticals, Inc. (XENE) CEO Simon Pimstone on Q2 2020 Results - Earnings Call Transcript
11:03am, Sunday, 09'th Aug 2020
Xenon Pharmaceuticals, Inc. (NASDAQ:XENE) Q2 2020 Earnings Conference Call August 06, 2020, 17:30 ET Company Participants Jodi Regts - VP, Corporate Affairs & IR Simon Pimstone - CEO & Directo
Fibre broadband plan includes €100 standard connection charge
08:00pm, Saturday, 08'th Aug 2020
Carrigaline townlands to be first connected to National Broadband Plan network
Dupont Capital Management Corp Purchases New Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
07:04am, Wednesday, 05'th Aug 2020
Dupont Capital Management Corp purchased a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) in the second quarter, according to the company in its most recent Form 13F filing with the Securitie
NASDAQ Rises for Fifth Straight Day and Logs Another New High
12:00am, Wednesday, 05'th Aug 2020
Stocks Analysis by Zacks Investment Research covering: McDonald’s Corporation, Neurocrine Biosciences Inc, Diebold Nixdorf Inc, Treehouse Foods Inc. Read Zacks Investment Research's latest article o
Building An Investment Portfolio: July 2020 Update And 3 Buys
10:21pm, Tuesday, 04'th Aug 2020
Don't underestimate the power of compounding of the growth stocks. The future growth may not always be priced in and may compensate even if you end up paying more.
Charting a solid August start: S&P 500, Nasdaq stage latest summer breakouts
04:38pm, Tuesday, 04'th Aug 2020
Technically speaking, the U.S. benchmarks’ bigger-picture backdrop remains bullish amid a solid August start, writes Michael Ashbaugh.
Neurocrine Biosciences Inc (NBIX) Q2 2020 Earnings Call Transcript
01:30pm, Tuesday, 04'th Aug 2020
NBIX earnings call for the period ending June 30, 2020.
Ingrezza Remains Surprisingly Strong For Neurocrine (NASDAQ:NBIX)
12:39pm, Tuesday, 04'th Aug 2020
Ingrezza sales, boosted by inventory-building, once again posted a double-digit beat to expectations, as sales grew 48% from the prior year.
How Is Neurocrine Biosciences' (NASDAQ:NBIX) CEO Paid Relative To Peers?
12:38pm, Tuesday, 04'th Aug 2020
This article will reflect on the compensation paid to Kevin Gorman who has served as CEO of Neurocrine Biosciences...
How Neurocrine Biosciences Crushed It in Q2
10:34am, Tuesday, 04'th Aug 2020
Neurocrine Biosciences' (NASDAQ: NBIX) 30% plunge earlier this year during the coronavirus-fueled market meltdown is practically all but forgotten now. Here's what you need to know about Neurocrine's
Number fever: The Pepsi contest that became a deadly fiasco
10:23am, Tuesday, 04'th Aug 2020
DECADES ago, a marketing stunt promised Philippine soda drinkers a chance at a million pesos. But an error at a bottling plant led to 600,000 winners—and to lawsuits, rioting, and even deaths.
Nisa Investment Advisors LLC Sells 14,860 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
06:52am, Tuesday, 04'th Aug 2020
Nisa Investment Advisors LLC decreased its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) by 65.5% during the second quarter, according to the company in its most recent disclosure with the Se
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 3)
ABIOMED, Inc. (NASDAQ: ABMD)
ALX Oncology Holdings Inc (NASDAQ: ALXO)
Annexon Inc (NASDAQ: ANNX)
Atossa...
Neurocrine Biosciences (NBIX) Surpasses Q2 Earnings and Revenue Estimates
09:15pm, Monday, 03'rd Aug 2020
Neurocrine (NBIX) delivered earnings and revenue surprises of 24.62% and 18.28%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
